PMID- 24334446 OWN - NLM STAT- MEDLINE DCOM- 20140225 LR - 20230701 IS - 1552-5783 (Electronic) IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 55 IP - 1 DP - 2014 Jan 13 TI - Fcgamma receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration. PG - 247-58 LID - 10.1167/iovs.13-11821 [doi] AB - PURPOSE: Several lines of evidence suggest the involvement of antibodies and immune complex inflammation in AMD, a blinding disease with a strong inflammatory component. To examine this further, we developed a novel experimental mouse model of retinal inflammation and evaluated whether inflammation associated with immune complex formation was present in eyes of AMD donors. METHODS: A localized immune complex-mediated reaction was induced in the retina of wild-type (WT), Fc receptor gamma chain-deficient (gamma(-/-)), and C1q-deficient (C1q(-/-)) mice, and donor eyes were obtained after death from donors with early or wet AMD and from healthy control subjects. The presence of immune complexes, Fcgamma receptors (FcgammaRs), and markers of macrophage/microglia activation was investigated by immunohistochemistry. RESULTS: In WT and C1q(-/-) mice, immune complex deposition in the retina led to a robust inflammatory response with activation of microglia, recruitment of myeloid cells, and increased expression of FcgammaRI through FcgammaRIV and major histocompatibility complex class II. This response was not observed in gamma(-/-) mice lacking activating FcgammaRs. We found that early AMD was associated with deposition of IgG, C1q, and membrane attack complex in the choriocapillaris and with increased numbers of CD45+ cells expressing FcgammaRIIa and FcgammaRIIb. Furthermore, FcgammaRIIa and FcgammaRIIb were observed in eyes of donors with wet AMD. CONCLUSIONS: Our studies suggest that immune complexes may contribute to AMD pathogenesis through interaction of IgG with FcgammaRs and might inform about possible adverse effects associated with therapeutic antibodies. FAU - Murinello, Salome AU - Murinello S AD - Centre for Biological Sciences, University of Southampton, Southampton General Hospital, Southampton, United Kingdom. FAU - Mullins, Robert F AU - Mullins RF FAU - Lotery, Andrew J AU - Lotery AJ FAU - Perry, V Hugh AU - Perry VH FAU - Teeling, Jessica L AU - Teeling JL LA - eng GR - WT_/Wellcome Trust/United Kingdom GR - R01 EY017451/EY/NEI NIH HHS/United States GR - EY-017451/EY/NEI NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20140113 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (Receptors, IgG) SB - IM MH - Animals MH - Disease Models, Animal MH - Enzyme-Linked Immunosorbent Assay MH - Humans MH - *Immunity, Innate MH - Immunohistochemistry MH - Inflammation/*genetics/immunology MH - Macular Degeneration/*genetics/immunology/metabolism MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Receptors, IgG/biosynthesis/*genetics/immunology MH - *Up-Regulation PMC - PMC3891269 OTO - NOTNLM OT - Fc receptor OT - immune complex OT - immunoglobulin OT - inflammation OT - macular degeneration EDAT- 2013/12/18 06:00 MHDA- 2014/02/26 06:00 PMCR- 2014/07/01 CRDT- 2013/12/17 06:00 PHST- 2013/12/17 06:00 [entrez] PHST- 2013/12/18 06:00 [pubmed] PHST- 2014/02/26 06:00 [medline] PHST- 2014/07/01 00:00 [pmc-release] AID - iovs.13-11821 [pii] AID - 10.1167/iovs.13-11821 [doi] PST - epublish SO - Invest Ophthalmol Vis Sci. 2014 Jan 13;55(1):247-58. doi: 10.1167/iovs.13-11821.